







RE: ENSC 405W Proposal for The Kompression Shirt
Dear Dr. Scratchley,
Please find attached a document containing the proposal of the Kardiographic Medical
Solutions (KMS) product, Kompression. Our goal is to change the way we can view and track our
own cardiovascular health by making a product that offers convenient monitoring, free of the
inconvenience of scheduling doctor appointments. This will be accomplished in the form of a
wearable electrokardiogram (EKG) compression shirt that will transfer cardiovascular signals and real
time analysis to one's smartphone.
This document will demonstrate our project scope and include a system overview along with
outlining risks and benefits. It will not only provide a summary of similar products competing in our
target market but also give insight into our company costs and funding. Finally we will give a brief
description of the core values of our company and an introduction to each of our members at KMS.
On behalf of Kardiographic Medical Solutions, our team would like to thank you for your
time in reviewing and assessing our proposal. Should you have any questions, comments or















Heart disease currently affects 2.4 million Canadians [1] with the number young adults being
affected increasing every year. However this issue goes beyond Canadian borders. In North America,
heart issues are the leading cause of death accounting for twenty five percent of all recorded deaths
[2]. Many individuals do not get diagnosed in a timely manner, resulting in prolonged effects of
ischemic heart disease. Wouldn’t it be great if there was a tool available that could easily monitor
your cardiac activity and share that information with a physician?
Kardiographic Medical Solutions (KMS) is a company set on solving early diagnosis issues for cardiac
health. We were founded on the idea of being the “monitor for the world's heart”. Our goal is to
provide accurate and reliable cardiac measurements that can potentially double in a clinical setting
for physician diagnosis. We were created by four engineering students from Simon Fraser University
set on making a change in the health and wellness market. The team brings together a diverse skill
set ranging from software to biomedical electronic expertise to present our product, Kompression.
Kompression is a wearable long sleeve shirt capable of recording a 4 lead EKG and a pulse oximeter
reading at any time of the day, during any type of activity. All of these measurements are transmitted
via a small electronic module on the side of the shirt to a cellular device. The readings are then stored
as an easily shareable file in a personal cardiac diary listing measurements by the date they have been
taken. The shirt is revolutionary in its design being the among the first in development. Our
competitors provide products with 1-lead EKG abilities through a chest strap or finger monitors.
However, Kompression offers more leads and extra features without limiting user movement and
provides a system of diagnosis linking the user with their physician.
Currently in the US, the wearable technology market size is valued at USD 29.76 billion dollars with
a potential to expand at a rate of 26.4%% per year until 2027 [6]. This market is driven by
individual’s concerns of obesity and chronic diseases [3] and we are very optimistic about
Kompression’s potential. Our product has not currently hit markets; but we are projected to make
$100,000 in sales by the end of 2022 if launched in January 2022. We are currently funded by
personal donations but have applied to SFU’s Wighton fund and are preparing an application for
BC’s Ignite program.
Kompression is a game changing wearable product that will help people globally get a real grip on
their health.  With the amount of public interest KMS has acquired, our team is confident that our
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Over  50,000 Canadians are diagnosed with heart failure every year with well over 1 million
Canadians having existing cardiovascular conditions [4]. It is now more important than ever to be
able to monitor your heart health so that you do not become another statistic. Most heart health
monitoring systems such as electrocardiograms (EKG’s) are currently limited to a trip to the doctors
office; which most people will only travel to after symptoms worsen and it is too late. With these
limitations, Kardiographic Medical Solutions (KMS) aims to find a solution of tracking one's heart
health in a convenient manner, with the introduction of the Kompression shirt product.
Kompression is a product that will allow its user to keep track of their heart health conveniently
through the implementation of a 4-lead, 5-electrode EKG monitoring system and pulse oximeter
built into a compression shirt, with displayable information presented via a mobile app. Kompression
will be ready for use wherever the user sees fit. Whether lifting weights in the gym, going out for a
run on the track field, or simply sitting at home and resting, Kompression will be the go to option
for monitoring anyone's cardiovascular system. Kompression aims to be the leader in the bodywear
sector being at the forefront for computer aided diagnosis of cardiac issues.
This proposal document aims to present an in depth look at the features and details necessary for
considering Kompressions viability within the market. We will start by providing a scope that will
outline Kompressions capabilities and functionality. This will be followed by reviewing the benefits
and risks that are involved in the creation of this project. We will then turn our focus onto the
market and competition section where we will describe our efforts in integrating Kompression into
an existing and very competitive wearable technology market. Project planning and cost
considerations will also be covered towards the end, covering major milestones, pricing for parts and
expected revenue within a specific time frame. Lastly we will conclude with information about the
Kardiographica Medical Solutions team and a summary of Kompression.
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2. Scope & System Overview
The end goal of Kompression is to provide the user with a high end analysis of their cardiac health
via an EKG system built into a compression shirt that will transmit displayable data straight to the
users mobile device (Figure 2.1). To accomplish this outcome the Kompression product is split up
into two complementary main components: the electrical/hardware components for recording and
transmitting the data, and the software components for analysing and displaying the measurement in
a comprehensible form.
Figure 2.1 System Overview
Kompression will feature an intuitive mobile companion application that will show real-time EKG
graphs for each of our four leads and keep track of past abnormal heart rhythm events. Furthermore
it will include a preliminary diagnosis report based on previous readings the user has taken. In
addition, Kompression will include a pulse oximeter sensor that will be integrated within our
software application. The pulse oximeter serves to provide extra measurements and to verify correct
EKG recordings. As a final product Kompression will be able to provide clear and concise EKG and
pulse oximetry measurements.  Our team is committed to creating an easy and intuitive system for
cardiac monitoring. However, like any novel product, Kompression suffers from some limitations,




On the physical compression shirt, there are 4-leads composed of 5 total electrodes. One right arm
electrode, one left arm electrode, and one left leg electrode making up 3 leads. This forms 3 bipolar
leads recording the frontal plane of the heart. The single electrode on the chest is used as a precordial
lead for a recording of the horizontal cardiac plane. The final electrode is placed as a right leg drive
which filters out a majority of any noise the signals can produce. These electrodes are all connected
by wiring running through the shirt and attaching into a common node where the EKG printed
circuit board (PCB) and arduino nano recording device are connected. The user will be able to
remove this device via connectivity pins and a locking mechanism for washing purposes.
2.2 Software Overview
The data being read in by the arduino nano is the voltage and timing data produced by the EKG
circuit and leads which will be transmitted via bluetooth to the users mobile device. This data is then
analysed using a real time implementation of the Pan Tompkins algorithm which is used to detect
and annotate QRS complexes used for calculating heart rate and heart variability. An arrhythmia
detection feature is also available for analysis of the data using a deep neural network. Different
Arrhythmia will be detected and classified on recorded EKG data.  This data is displayed to the user
in a matter that is easy to understand such as statistical charts, graphics, and numerics.
3. Benefits
Kompression is a novel product that has the potential to better people’s lives. It aims at improving the
lives of young adults by increasing the ability to measure and track cardiac health.
From a user standpoint, Kompression allows a better and more efficient way to record EKG and
pulse oximetry measurements. It allows the user to record a measurement at any given time of the
day and during any activity. This is beneficial for users of all backgrounds and physical abilities. A
more active user may want to keep tabs on his heart performance during a workout whereas a user
with a more sedentary lifestyle might want periodic updates on their cardiovascular system. The ease
of access to such a tool is not only key in monitoring and detecting early problems but also
advantageous to those looking for performance markers in athletic training. Furthermore,
Kompression’s ability to store biopotential measurements allows the user to share whatever
information they feel necessary with their physician. This in turn, could reduce wait times in health
clinics for users actually experiencing health issues.
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The entire Kompression system is intuitive and requires no previous technical experience. Electrodes
and pulse oximeter sensors are clearly marked on the inside of the shirt along with the measuring
device. All wires are embedded within the shirt fabrics giving Kompression a clean and neat look.
This all comes paired with an application available on all platforms that stores and tracks
measurements taken. Users are able to view their data instantly without waiting for results. From
there, what they do with the data is their choice.
4. Risks
With a novel product like Kompression, comes a certain set of potential risks users should look out
for. First, EKG measurements might not be up to clinical standards. Many different factors could
cause this, but the two most common are dirty skin and constantly moving electrodes. A bad
measurement would make communication between user and physician more difficult as EKG
readings need to be of a certain standard.
Second, the Kompression shirt might be difficult to wash. Washing the shirt requires users to remove
electrodes from their place and reattach them after the wash cycle. This reattachment process might
not be intuitive and be a reason for poor measurements. The wash cycle might also damage
connection ports and wiring within the shirt. Even though Kompression states that this is not an
issue, it is a possible risk. Furthermore, the shirt could shrink which would be another cause for
improper measurements.
Third, if proper power standards are not adhered to, the entire measuring device might break which
could result in current flowing into the user. Improper powering would also result in faulty
measurements. The design team has placed clear indicators next to the battery ports indicating
proper device powering.
Lastly, risks of false readings and analysis might pose a large problem to users. A false reading poses
huge issues to our company and product credibility. A handful of problematic measurements and
analysis could result in market loss. However, our team is confident this will not be an issue.
Extensive testing has not shown improper measurements.
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6. Market & Competition
6.1 Wearable Technology Market
As of 2019,  the global wearable medical devices market size was USD 29.76 billion and with its
current growth in the last couple of years, it is projected to reach USD 197.57 billion by 2027,
exhibiting a Compound Annual Growth Rate (CAGR) of 26.4% during the forecast period. [6]. This
market includes a wide range of medical devices that customers can wear on their daily activities,
such as, activity trackers, smartwatches, and many others. These are specially designed to monitor
and collect the data of a user’s health and fitness. For our product, Kompression, we are a subset of
this market, as we are trying to target the wearable technology market that specializes in the use of a
portable and wireless EKG monitoring device. Our product is targeted towards individuals who are
looking to monitor their heart health over time and want to get a preliminary diagnosis on any
abnormal heart rhythms they may experience at an early stage.
6.2 Mobile EKG Market
Kompression is a mobile EKG device as it allows the data to be transmitted wirelessly via bluetooth
to our application called KardioCare, where data is processed and analyzed before giving a
preliminary diagnosis to the user. Given this description, Kompression is part of the ever growing
mobile EKG market. This market area has a lot of room for innovative solutions and is expected to
continue its growth at a fast pace over the coming years. The mobile ECG market was valued at
USD 80.50 billion in 2018 and is projected to reach USD 123.82 billion by 2026, growing at a
CAGR of 5.50% from 2019 to 2026. [5], This allows us to explore and innovate around this
booming market and bring our product to the hands of millions of people around the world.
6.3 Driving Forces
In the US, it has been observed that the adoption of wearable types of medical devices increased from
9.0% back in 2014 to 33% in 2018 which heavily shows how more and more people are becoming
more reliable on these medical devices to keep a healthy lifestyle [6]. Similarly, with the increase of
chronic diseases due to the lack of regular healthcare visits from the population, we have observed an
increase in the need of wearable devices that can offer various vital sign monitoring capabilities, such
as, heart rate, SpO2, blood glucose, etc. From these facts, we get that our key factors driving this
market revolve around the increasing prevalence of chronic diseases and the growing awareness




In terms of competition, Kompression, faces off against many highly popular brands such Apple with
their smartwatch solution, the Apple Watch, AliveCor, with their solution, KardiaMobile, and
Qardio with their QardioCore device. Looking at the Apple Watch, it allows users to monitor their
heart signal and detect atrial fibrillation, which is the most common type of irregular heartbeat and a
major risk for stroke. The downside of this device is that it can only replicate a single-lead EKG
system which cannot accurately describe all the different views from the heart as a regular 12-lead
EKG system that doctors normally use. Given that our product, Kompression, will specialize solely
on perfecting the detection and classification of abnormal cardiac rhythms, it will give us an edge
over these smartwatches since it will allow for a much better early diagnostic tool that people can use
in the comfort of their own homes.
Another competitor is manufactured by AliveCor, an american medical device and artificial
intelligence company that sells EKG hardware and software. Their latest product is called
KardiaMobile 6L, which is a wireless personal EKG monitor that can take a single-lead or 6-lead
EKG measurements, with access to a subscription service to get results analyzed by professionals
every 30 days. Their EKG lead design is fairly innovative and they use a similar approach to what
Kompression will do, by having more electrodes in the device to guarantee a better view of the
heart, but by Kompression not having a subscription service and being able to provide similar
features, it will attract their customers to choose Kompression over KardiaMobile.
Our other competitor is by a company named Qardio which have developed the QardioCore
solution, which, from some reviews, is labeled as a 3-lead EKG system that goes in the user's chest
area which mimics closely to how Kompression will be used. This device supports continuous
wireless EKG monitoring, skin temperature, respiratory rate and heart rate variability [7]. This
solution, however, only detects heart rate variability without diagnosis prediction which is a big
difference from Kompression which will do both in a single application.
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What makes Kompression a more powerful and competitive solution amongst our competitors is
that we can provide more detection patterns by utilizing machine learning algorithms with data
from millions of patients. We will not feature any subscription service that could act as a barrier to
our customers and instead allow customers to have access to their data at any time, ready to be
exported for further analysis by their own medical professional. Additionally our measurements can
be taken at any moment without limiting the user’s movement. Some of the key specifications
differences and similarities between competitors and Kompression are outlined below in Table 6.1.
Device Lead system ADC Bits Detection analysis Cost ($ CAD)
Kompression 4-lead 10-bit Detects atrial fibrillation, 1st
degree AV block, right and
left bundle branch block,
sinus bradycardia and
tachycardia, and normal
heart rhythm. Will also







1-lead N/A Detects only atrial fibrillation








QardioCore 3-lead 16-bit Detects continuous ECG,
heart rate and HRV but
without diagnosis prediction
$556




All major processes and milestones of the Kompression shirt have been organized into two main
phases: a proof of concept (PoC) prototype and an engineering prototype.
The PoC prototype will prove the viability of the foundational features of the Kompression shirt and
will include:
● Application correctly connecting and displaying live EKG data from a single lead breadboard
circuit
● Example validation testing of the arrhythmia detection
● An appearance prototype consisting of a shirt and device demonstrating the final size and
shape
To achieve this functionality for the PoC prototype we have followed the schedule of milestones (red
bars) and key processes (blue bars) presented in Figure 7.1.
After the PoC prototype has proved the main technologies, we will focus on iterating towards a full
featured and integrated Kompression shirt engineering prototype.
The engineering prototype will include:
● Integration of the arrhythmia detection into the application
● Integration of HR, HRV into the application
● All four EKG leads
● Customized PCB for the device
● Custom case and battery for the device
● Integration of the electrodes, shirt and device
These objectives will be achieved by following the schedule in Figure 7.2. After the engineering
prototype is complete, a future phase will only need to make minor optimizations to make the
Kompression shirt market viable.
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Figure 7.1 PoC Timeline (Phase A)
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Our base cost projections including both proof of concept phase and prototyping phase have been
calculated to be ~ $338.27 (Table 8.1). This of course is an estimation and can vary depending on
multiple factors, which is why we will give or budget a 25% increase in contingency plans should
not everything go as planned bringing our total budget to $422.84. All costs are in $CAD.
8.1 Cost Projections
Item Cost/Unit Quantity Cost/Quantity Phase (Alpha/Beta)
Arduino Nano $34.66 1 $34.66 A/B
Bluetooth Module $14.99 1 $14.99 A/B
Instrumentation Amp $43.00 1 $43.00 A/B
10ft 22 Gauge Wiring $1.40 5 $7.00 A/B
Bread Board $9.99 2 $18.98 A
Digital Multimeter $30.00 1 $30.00 A/B
Capacitor Kit $27.00 1 $27.00 A/B
Resistor Kit $14.99 1 $14.99 A/B
Nylon-Spandex Fabric $23.49 1 $23.49 A/B
Compression Shirt $19,99 1 $19.99 A/B
PCB $15.99 3 $47.94 B








Since laboratories have been closed items such as resistors and capacitors are not readily available,
causing the cost of the product to be increased. Although Kompression is not the most expensive
product to prototype and manufacture, there are still many outlets in which we can cut down costs
coming out of our own pockets. There are multiple funds that SFU offers that can provide assistance
in cutting down the total cost of Kompression. The top three options are the Engineering Science
Student Endowment Fund, the Wighton Engineering Development Fund, and the IEEE Student
Project Fund. These awards all require different applications and different acceptance criteria. A
version of this proposal will likely be submitted as the Wighton Engineering Development Fund
application. Although this project does not completely break the bank, we will be considering these
awards as a means to provide financial assistance.
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9. About the Company
Kardiographic Medical Solutions was founded early in January 2021 by four engineers from Simon
Fraser University. They all came together under the idea that cardiac monitoring needed to be more
prevalent in people's lives. From this idea, the company motto “Monitoring the heart Health of the
World” was created. This motto is what KMS stands by and strives towards.
Meet the Team:
Diego Martin - Chief Executive Officer
Diego Martin is currently finishing his major in Computer Engineering at SFU and enjoys working
with software, involving task automation and creating interactive games using Unity. He is part of
the software team at KMS and is working on building our application that will interact with the
hardware component. Has done multiple co-op experiences in both hardware and software. From
his most recent co-op placement at Avigilon, as part of their firmware validation team, he has gained
exposure to CI/CD practice and python scripting for automating manual tests. Outside of work, he
enjoys learning new programming languages and frameworks and loves playing table tennis and
foosball.
Stefan Ungurean - Chief Communications Officer
Stefan Ungurean is a 5th Biomedical Engineering student with a focus in signal processing and
electronics. He is part of the hardware team at KMS and worked on designing the circuitry and
signal processing algorithms for Kompression. He prides himself in his ability to create novel
products and is always excited at the possibility of furthering his technical experience. Outside of
work Stefan enjoys running and is a chess enthusiast.
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Jamyl Johnson - Chief Financial Officer
Jamyl in his 5th year as an applied science student majoring in computer engineering. He has had
the experience of working co-op jobs with three separate companies for a running total of 16
months. He has been a Junior Technical Engineer at Canadian Pacific, a Technical Services Student
at Pembina and is currently working part time at Environment and Climate Change Canada as a
Programmer/Data Analyst. Jamyl works closely with Stefan as a part of the Hardware team at KMS
which focuses on circuitry implementation and EKG readings of Kompression. To balance his
work/lifestyle he enjoys listing weights in the iron domain and is a fine acoustic guitarist.
Matthew Gould - Chief Technology Officer
Matthew is a 5th year computer engineering student with experience utilizing software in
interdisciplinary fields. He has created and contributed to open source projects while working with
the MAGPIE (Mathematics, Genomics and Prediction in Infection and Evolution) research group at
SFU. As part of the software team at KMS he will be applying his skills towards development of the
EKG analysis and user interface components of the application for the Kompression device. Beyond




Kompression is a novel cardiac recording device bound to change the wearable technology and
wellness markets. It’s ability to record EKG signals along with pulse oximetry measurements during
any activity allow us to offer users more flexibility surrounding cardiac monitoring. Kompression
uses a 4-lead EKG system to track heart rhythms throughout the day. All wirings and electrodes are
expertely embedded within the shirt for maximum comfortability. Our hardware system paired with
our easy and intuitive software makes Kompression a real contender for commercial markets. With
Kompression it becomes easy to track your health and performance at the touch of a finger.
Our competitors do not offer the extent of features on their recording devices and our product does
not restrict the movement of users. KMS is jumping on the growing wearable market and with
Kompression, looks to be one of the best and most reliable companies in the sector. Our costs are
low and we are currently well funded with high revenue projections in the coming years. Our final
product looks to be developed by August 2021 with a working prototype by mid April 2021.
Despite certain risks presented, Kompression will do its best to mitigate and reduce common
problems that lead to improper usage and damage. The product will come equipped with manuals
and clearly labelled parts to reduce any confusion on product usability. Kompression is a product
worth investing in due to its multiple health monitoring benefits and its ability to reduce waiting
times in clinics. It is the new way of health monitoring and computer aided diagnosis ready to break
the market. KMS is proud to be able to offer the Kompression shirt to users everywhere. The entire
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